~~<i id='281AC8C1CE'><strike id='281AC8C1CE'><tt id='281AC8C1CE'><pre id='281AC8C1CE'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：explore 2025-09-27 23:53:27 - browse：5363

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Microsoft's Peter Lee: Generative AI could help doctors be more human

hotspot

knowledge

focus

leisure time

Advancesingenetherapycouldeventually"cure"manyformsofcongenitaldeafness.Thechangeshavemanydeafpeople

WSS

Why Talkspace is targeting Medicare, a tricky market

Do more moles mean more problems? Not so, says new study

Scientists successfully use ultrasound imaging to map brain activity

Medicare drug price negotiation hearing pits pharma v Biden admin

What will save rural psychiatry services? Higher Medicaid payments

Families look for replacement for GSK asthma drug Flovent

knowledge

leisure time

hotspot

Activists slam private health insurers over coverage restrictions

Insmed lung disease drug hits target in key Phase 3 trial

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Change Healthcare: What is it, why does its cyberattack matter?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Activists slam private health insurers over coverage restrictions

Ancient Greek ideas underpin modern concepts of pregnancy

New air purifier tech could be key to improving indoor air quality

Scientists successfully use ultrasound imaging to map brain activity

knowledge

Streamlined flu vaccines recommended by FDA advisory panel

Prosthetic arm enables patients to feel the objects they grip

State of the Union pitch: Bigger Medicare drug price negotiations

A new approach to psychiatric drug development

Do more moles mean more problems? Not so, says new study

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

knowledge

focus

focus

leisure time